L-arachidoyl carnitine

metabolite

L-arachidoyl carnitine accumulates in myocardial necrosis, serving as an early ischemia and cardiomyocyte damage marker.

Pathway placement

Cascade stepMyocardial injury (shared endpoint)

Confidencemedium

RationaleEarly AMI diagnostic biomarker reflecting cardiomyocyte lipid injury.

Druggability

Not assessed (no mapped human gene target).

Assay & specimen

Class-level default (no specific cleared assay)— generic method inferred from analyte class; confirm against a specific product insert before use.

Specimen

Serum, plasma or urine

Collection tube

Serum separator (gold/red-top, SST) · Lithium heparin (green-top) · Sterile urine container

Method / principle

LC-MS/MS (targeted metabolomics) or enzymatic colorimetric where available

Reagent / substrate

Stable-isotope-labeled internal standard (MS); or enzyme-coupled Trinder reagent

Platform

LC-MS/MS; some automated chemistry

Turnaround · availability

Send-out / research · Specialized / research